News | August 08, 2025
Sigachi begins construction work for MCC capacity expansion at Dahej
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
The transaction enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide
The plant will have installed production capacity of 3,120 MT/month
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Increases speed to market for drug developers working on nucleic acid therapeutics
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
Subscribe To Our Newsletter & Stay Updated
